Asthma: race-related differences in eosinophilic airway inflammation

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
Takeaway
  • There are race-related differences in eosinophilic airway inflammation among asthmatic patients receiving inhaled corticosteroids (ICS).

Why this matters

  • Increased risk of eosinophilic inflammation in ICS-treated (ICS+) African-Americans may reflect corticosteroid insensitivity.

Key results

  • 17% of ICS+ participants had eosinophilic airway inflammation, with no significant differences between African-Americans and Caucasians. 
  • African-Americans with eosinophilic inflammation were twice as likely to have mixed granulocytic pattern (7% vs 3%; P=.02) and less likely to exhibit neutrophilic inflammation (71% vs 75%; P=.02). 
  • 36% of subjects not treated with ICS (ICS-) had eosinophilic inflammation, with no significant difference between African-Americans and Caucasians (39% vs 35%; P=.65). 
  • ICS- African-Americans with eosinophilic inflammation were 4 times as likely to have mixed granulocytic infl...